Comparison of Outcomes With Multifocal Intraocular Lenses (NCT02678962) | Clinical Trial Compass
UnknownNot Applicable
Comparison of Outcomes With Multifocal Intraocular Lenses
China90 participantsStarted 2016-02
Plain-language summary
The purpose of this study is to compare and evaluate the clinical outcomes of 6 kinds of Multifocal Intraocular Lenses: SN6AD1, SBL-3, LS-313 MF30, AT LISA tri 839 MP, ART, LS-313 MF30T.
Who can participate
Age range
40 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age from 40 to 80 years old, either gender;
* Patients with bilateral age related cataracts, require bilateral cataract phacoemulsification combined Intraocular Lens implantation;
* Willing to undergo second eye surgery within 7 days after first eye surgery;
* The potential postoperative visual acuity of 20/40 or better in both eyes;
* Preoperative measurement of corneal astigmatism indicate the subjects are suitable for multifocal intraocular lenses implantation;
* Capability to understand the informed consent and willing and able to attend study
Exclusion Criteria:
* Preexisting ocular diseases or conditions other than age related cataracts, have contraindications for cataract surgery;
* Preexisting systemic diseases or conditions that may confound the results of the study;
* Previous ocular surgery history or ocular trauma that may confound the results of the study;
* Require combined surgery that may confound the results of the study;
* Previous participation in other clinical trial within 30 days of this study start;
* Systemic or ocular medications that may confound the outcome of the intervention
* Pregnant, lactating, or planning to become pregnant during the course of the trial;
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Uncorrected Visual Acuity (UCVA) at Distance, Near
Timeframe: 3 months after surgery
2
Best distance corrected Visual Acuity at Distance, Near
Timeframe: 3 months after surgery
3
Defocus curve
Timeframe: 3 months after surgery
4
Contrast sensitivity
Timeframe: 3 months after surgery
5
Ocular aberration
Timeframe: 3 months after surgery
6
Ocular Scatter Index measured by Optical Quality Analysis System(OQAS) II
Timeframe: 3 months after surgery
7
Modulation Transfer Function (MTF) cut-off measured by OQAS II